Kevin D. Loutherback is a notable inventor based in Emeryville, CA, with a significant contribution to the field of microfluidics. He holds two patents that focus on innovative methods for sorting T lymphocytes, essential for advancements in immunology and biotechnology.

Latest Patents

One of Loutherback's latest patents is titled "Sorting of T lymphocytes in a microfluidic device." This patent describes methods for effectively flowing fluid samples containing T lymphocytes through specialized regions of microfluidic devices. The technology utilizes an array of posts, designed with critical sizes to differentiate activated T lymphocytes from naïve counterparts. Additionally, the patent includes microfluidic devices specifically engineered for this separation, along with compositions enriched in activated T lymphocytes reactive to particular antigens. This innovation holds significant potential for treating pathogenic disorders and cancers by administering targeted therapies.

Another notable patent he has developed is focused on "Methods, systems and kits for in-pen assays." This patent outlines techniques and systems for detecting assay results, leveraging the differential diffusion rates of reporter molecules and analytes within a microfluidic environment. This method allows for the quantification of biological micro-objects' secreted products, enhancing the capabilities of biochemical analysis.

Career Highlights

Kevin Loutherback is currently employed at Berkeley Lights, Inc., a company renowned for its innovations in bioengineering and microfluidic applications. His work contributes to the growth of technologies that streamline biological research and have practical applications in clinical settings.

Collaborations

Throughout his career, Loutherback has collaborated with notable colleagues, including Troy A. Lionberger and Matthew E. Fowler. Their collective efforts aim to advance microfluidic technologies, further promoting improvements in the efficiency of biological assays and cellular analysis.

Conclusion

Kevin D. Loutherback’s innovative contributions to microfluidic technologies highlight his importance in the field of biomedical research. His patents demonstrate a commitment to enhancing methodologies for T lymphocyte sorting and developing efficient assay systems, which are crucial for improving therapeutic strategies in healthcare. As he continues to work with Berkeley Lights, Inc., his influence on the industry is expected to grow, paving the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.